SPAREN 400MG TABLET by Horizon Pharma contains Sparsentan 400mg, a dual-acting medication used in appropriate adults with primary IgA nephropathy (IgAN) who are at risk of disease progression.
Sparsentan works by blocking two important pathways involved in kidney damage: the endothelin A (ETA) receptor and the angiotensin II type 1 (AT1) receptor. By targeting both pathways, Sparsentan may help reduce harmful effects such as increased blood pressure, inflammation, and protein leakage through the kidneys.
SPAREN 400MG is a prescription medicine and should be used only under the supervision of a qualified healthcare professional. Kidney function, blood pressure, potassium levels, and other laboratory parameters may require monitoring during treatment.
Sparsentan is used in appropriate patients with primary IgA nephropathy who are at risk of kidney disease progression.
Sparsentan blocks both ETA and AT1 receptors, targeting two pathways that can contribute to kidney injury.
By affecting pathways involved in kidney damage, Sparsentan can reduce protein leakage into the urine in appropriate patients.
Blocking the angiotensin II pathway can contribute to lowering blood pressure.
Clinical treatment with Sparsentan may help reduce the risk of kidney function decline in eligible patients with IgA nephropathy.
SPAREN 400MG provides a 400mg strength of Sparsentan for prescribed treatment.
SPAREN 400MG TABLET is supplied under the Horizon Pharma brand according to the provided product information.
SPAREN contains Sparsentan, which has dual receptor-blocking activity.
Endothelin-1 can promote blood vessel constriction and contribute to processes associated with kidney injury. Sparsentan blocks the ETA receptor, reducing the effects of endothelin-1.
Sparsentan also blocks AT1 receptors activated by angiotensin II. This can reduce vasoconstriction, blood pressure, and certain processes associated with kidney damage.
By blocking both pathways, Sparsentan may help reduce proteinuria and protect kidney function in appropriate patients with IgA nephropathy.
Sparsentan may be prescribed for:
Treatment should always be individualized by a nephrologist or other qualified healthcare professional.
SPAREN may be considered for eligible adults with:
Your healthcare professional will assess kidney function, blood pressure, pregnancy status, potassium levels, and other medicines before prescribing Sparsentan.
| Active Ingredient | Strength | Function |
|---|---|---|
| Sparsentan | 400mg | Dual ETA and AT1 receptor antagonist used in appropriate patients with IgA nephropathy |
Take SPAREN exactly as prescribed by your doctor.
General guidance:
Your doctor will determine the appropriate treatment regimen for your condition.
If you miss a dose, follow the instructions provided by your healthcare professional or the product leaflet.
Do not take extra tablets to compensate for a missed dose unless specifically instructed by your doctor.
Like all medicines, SPAREN 400MG may cause side effects.
Laboratory changes may occur without noticeable symptoms, which is why regular monitoring is important.
Sparsentan can lower blood pressure. Contact your healthcare professional if you experience severe dizziness, fainting, or unusual weakness.
Sparsentan may increase blood potassium levels.
Seek medical attention for symptoms such as:
Your doctor may monitor serum potassium during treatment.
Changes in kidney function may occur during treatment. Regular kidney function testing may be recommended.
Sparsentan may cause swelling or fluid retention in some patients.
Tell your doctor if you notice significant swelling, rapid weight gain, or shortness of breath.
Before taking SPAREN 400MG, tell your doctor if you:
Your healthcare professional should review your complete medication list before treatment.
SPAREN should not be used during pregnancy.
Sparsentan can cause fetal harm because it affects the renin-angiotensin system.
Women who can become pregnant should discuss appropriate contraception with their healthcare professional before and during treatment.
If pregnancy occurs while taking SPAREN, contact your healthcare professional immediately.
It is not recommended to breastfeed during treatment with Sparsentan unless specifically advised by your healthcare professional.
Discuss treatment and feeding options with your doctor.
Tell your doctor or pharmacist about all medicines you take, including prescription medicines, OTC products, vitamins, and supplements.
Important interactions may involve:
Do not start or stop any medication without medical advice.
Your healthcare professional may monitor:
Regular monitoring helps your doctor determine whether SPAREN is safe and effective for you.
Contains Sparsentan 400mg for prescribed treatment.
Targets both ETA and AT1 receptors.
Used in appropriate patients with primary IgA nephropathy at risk of disease progression.
May reduce proteinuria and help protect kidney function in eligible patients.
Easy-to-administer oral tablet formulation.
SPAREN 400MG TABLET is supplied under the Horizon Pharma brand.
Sample/Placeholder Reviews – for demonstration only
⭐⭐⭐⭐⭐ Ahmed K. – Lahore
"The ordering process was easy and the product arrived securely packed."
⭐⭐⭐⭐⭐ Sana R. – Karachi
"Good packaging and convenient delivery. The overall ordering experience was smooth."
⭐⭐⭐⭐⭐ Hassan M. – Islamabad
"Received the product safely and the package was properly packed."
| Product Information | Details |
|---|---|
| Brand | HORIZON PHARMA |
| Product Name | SPAREN 400MG TABLET |
| Generic | Sparsentan |
| Strength | 400mg |
| Dosage Form | Tablet |
| Pack Size | 14 Tablets |
| Drug Class | Endothelin A & Angiotensin II Type 1 Receptor Antagonist |
| Primary Use | Primary IgA Nephropathy |
| Medicine Type | Prescription Medicine |
SPAREN 400MG contains Sparsentan and is used in appropriate adults with primary IgA nephropathy who are at risk of kidney disease progression.
Sparsentan blocks both ETA and AT1 receptors, helping reduce pathways involved in blood vessel constriction, proteinuria, and kidney damage.
Yes. Sparsentan may increase blood potassium. Your healthcare professional may regularly monitor potassium levels during treatment.
No. Sparsentan can cause fetal harm and should not be used during pregnancy. Discuss appropriate contraception with your healthcare professional.
SPAREN 400MG TABLET by Horizon Pharma can be ordered through SuperCare Pharma, subject to availability and prescription requirements.
Choose SuperCare Pharma for a convenient online pharmacy experience in Pakistan.
✔ Genuine pharmaceutical products
✔ Secure online ordering
✔ Convenient delivery across Pakistan
✔ Carefully packed orders
✔ Competitive pricing
✔ Customer support
SPAREN 400MG is a prescription medicine. Use it only under the supervision of a qualified healthcare professional.
Looking for SPAREN 400MG TABLET (Sparsentan 400mg) in Pakistan?
Order SPAREN 400MG TABLET by Horizon Pharma through SuperCare Pharma for convenient online ordering and reliable delivery.
Sparsentan should be used exactly as prescribed. Regular blood pressure, potassium, kidney function, and other monitoring may be required during treatment.
